<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5286360 Figure_1-A</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-C) Immunoblots of Gp96 and NMHCIIA levels from whole cell lysates (WCL) and Gp96 IP fractions (IP Gp96) of HeLa cells: (A) left untreated or treated with increasing concentrations of LLO for 15 min. (A, C) Quantifications of NMHCIIA in IP Gp96 are the mean&#177;SEM (n&#8805;3) (a.u. - arbitrary units).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_1-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Immunoblots of Gp96 and NMHCIIA levels from whole cell lysates (WCL) and Gp96 IP fractions (IP Gp96) of HeLa cells: (B) left uninfected (U) or infected with wt or &#916;hly Lm for 1 h. (A, C) Quantifications of NMHCIIA in IP Gp96 are the mean&#177;SEM (n&#8805;3) (a.u. - arbitrary units).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_1-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Immunoblots of Gp96 and NMHCIIA levels from whole cell lysates (WCL) and Gp96 IP fractions (IP Gp96) of HeLa cells: (C) infected with wt Lm for the indicated time points. (A, C) Quantifications of NMHCIIA in IP Gp96 are the mean&#177;SEM (n&#8805;3) (a.u. - arbitrary units).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_1-D-E</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Confocal microscopy images of HeLa cells: (D) left untreated or treated with LLO (0.5 nM, 15 min), immunolabelled for NMHCIIA (green), Gp96 (red) and stained with DAPI (blue). Arrows point to various NMHCIIA-Gp96 positive cortical bundles in different cell. Insets show high magnification image (E) Quantification of Pearson's correlation coefficient (PCC) within: uninfected cells (U), LLO-treated cells, cortical NMHCIIA bundles or equivalent size control cellular ROI. (Ctrl ROI) Data are mean&#177;SEM (n=6); p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_1-F</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Confocal microscopy images of HeLa cells infected with wt or &#916;hly Lm for 6 h immunolabelled for NMHCIIA (green), Gp96 (red) Lm (blue) and stained with DAPI (white). Arrows indicate NMHCIIA-Gp96 cortical bundles at cortical sites close to wt Lm. (D and F) Scale bar - 10 &#956;m. See also Figs EV1 and EV2.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-A</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Sequential frames of time-lapse confocal microscopy sequence of LLO-treated HeLa cells expressing (A) GFP-NMHCIIA . LLO was added to culture medium 10 seconds before t0. DIC - differential interference contrast. (A) Arrows indicate NMHCIIA bundles at PM blebbing sites.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Sequential frames of time-lapse confocal microscopy sequence of LLO-treated HeLa cells expressing (B) simultaneously GFP-NMHCIIA and mcherry-KDEL. LLO was added to culture medium 10 seconds before t0. DIC - differential interference contrast. (B) Highlights depicting ER structures within NMHCIIA bundles and PM blebs. Arrows indicate cortical ER surrounding NMHCIIA accumulations, arrowheads indicate contact points between ER vesicles and NMHCIIA cables and asterisks point to ER vacuoles within PM blebs</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Confocal microscopy images of HeLa cells left untreated (Control) or treated with LLO (0.5 nM 15 min). Cells were stained with FITC-WGA (Plasma membrane, PM-red) and immunolabelled for NMHCIIA (green). Insets show PM blebs and arrows indicate recruitment of NMHCIIA bundles to PM blebs associated (1) or detached (2) from the cell body.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-D</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Immunoblots of Gp96 and NMHCIIA levels from Gp96 IP of HeLa cells left untreated (U) or treated with: LLO (0.5 nM, 15 min) (LLO) and (D) LLO pre-incubated with cholesterol (LLOCHT)</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-E</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Immunoblots of Gp96 and NMHCIIA levels from Gp96 IP of HeLa cells left untreated (U) or treated with: LLO (0.5 nM, 15 min) (LLO) and (E) LLO in medium supplemented with 140 mM K+(HighK+) and LLO in Ca2+-free medium Ca2+ (Ca2+free)</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-F</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Immunoblots of Gp96 and NMHCIIA levels from Gp96 IP of HeLa cells left untreated (U) or treated with: LLO (0.5 nM, 15 min) (LLO) and (F) LLO in the presence of 25 &#956;M blebbistatin (BB).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-G</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Confocal microscopy images of HeLa cells treated as indicated and immunolabelled for ER-KDEL (blue), NMHCIIA (green) and Gp96 (red).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-H</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Confocal microscopy images of HeLa cells treated with aerolysin and immunolabelled for NMHCIIA (green) and Gp96 (red). Insets show NMHCIIA bundles and arrows indicate association between Gp96 and NMHCIIA.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_2-I</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 2-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) Immunoblots of NMHCIIA and Gp96 levels from Gp96 IP of HeLa cells left untreated (U) or treated with LLO (0.5 nM, 15 min), SLO (1.5 &#956;g/ml, 30 min) (SLO) or aerolysin (0.2 nM, 40 min) (AL).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_3-A-D</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 3-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Confocal microscopy images of shCtrl, shGp96 or shNMHCIIA HeLa cells treated with LLO (0.5 nM, 15 min) and immunolabelled for KDEL-proteins (blue), NMHCIIA (green) and Gp96 (red). Insets show compact NMHCIIA bundles in shCtrl cells and dispersed NMHCIIA bundles in shGp96 cells. Scale bar - 10 &#956;m. (B-D) Quantification of the % of cells harbouring NMHCIIA bundles after incubation with (B) LLO (0.5 nM, 15 min), (C) aerolysin (0.2 nM, 40 min) or (D) with wt Lm. Values are the mean &#177;SEM (n&#8805;3), p-values were calculated using (B-C) one-way-ANOVA with Dunnett post hoc analyses and (D) two-tailed un-paired Student's t-test, *p&lt;0.5, ***p&lt;0.001. For shNMHCIIA, bundles were detected following actin staining (Fig EV3C).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_3-E-F-G</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 3-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(E-F) Number of (E) blebs per cell or (F) retracting blebs per cell evaluated by time-lapse microscopy analysis of LLO-treated shCtrl or shGp96 cells. shCtrl n=32 cells and shGp96 n=40 cells, p-values were calculated using two-tailed un-paired Student's t-test *p&lt;0.5. (G) Sequential frames of time-lapse microscopy analysis of LLO-treated HeLa cells expressing GFP-NMHCIIA (shCtrl, shGp96 and shCtrl with 25 &#956;M Blebbistatin - shCtrl-BB). LLO was added to culture medium 10 seconds before t0.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_3-H</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Immunoblots of Ser19-phosphorylated MRLC (pMRLC), MRLC and actin levels from shCtrl or shGp96 cells left untreated (U) or treated with 0.1 nM LLO for the indicated time points. Quantification of pMRLC levels corresponds to the mean &#177; SEM (n&#8805;3), p-values were calculated using one-way-ANOVA with Tukey post hoc analyses **p&lt;0.01, ***p&lt;0.001. See also Appendix Fig S2 and Fig EV3.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-A</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(Ai) Confocal microscopy images of LLO-treated HeLa cells immunolabelled for the indicated proteins. Insets show colocalization between NMHCIIA and WRAMP components at cortical bundles. (Aii) Quantification of Pearson's correlation coefficient (PCC) between NMHCIIA and the indicated proteins within entire LLO-treated cells, cortical bundles or equivalent size control cellular ROI (Ctrl ROI). For Calpain 2 cortical bundles were defined by actin staining. Data are representative of one experiment repeated 3 independent times with similar results. p-values were calculated using one-way-ANOVA with Tukey post hoc analyses ** p&lt;0.01; *** p&lt;0.001, ns - non significant</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblots of NMHCIIA, Gp96 and Filamin A levels from WCL and Gp96 IP of HeLa cells left untreated (U) or treated with LLO (0.5 nM, 15 min) (LLO).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblots of NMHCIIA and Gp96 levels from WCL and Gp96 IP of HeLa cells left untreated (U) or treated with 25 &#956;g/ml of Wnt5a for the indicated time.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-D</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Confocal microscopy images of HeLa cells untreated (Mock) or treated with 25 &#956;g/ml of Wnt5a for 30 min. Cells were immunolabelled for ER-KDEL (blue), Gp96 (red) and NMHCIIA (green). Arrows indicate polarised localization of NMHCIIA, ER-KDEL and Gp96 in Wnt5a-treated cells.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-E-H</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(E-F) Confocal microscopy images of shCtlr, shGp96 or shNMHCIIA HeLa cells stained for actin (red) and DAPI (blue) and immunolabelled for (E) NMHCIIA (green) or (F) focal adhesion kinase (FAK) (green). (A, D-F) Scale bar - 10 &#956;m. Insets show sites with focal adhesion points and arrows indicate stress fibers or distinct focal adhesion points. Quantification of the % of cells with (G) stress fibers or (H) focal adhesion points labelled by FAK.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_4-I-J</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 4-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(I-J) Wound closure assay. (I) Sequential frames of time-lapse microscopy of HeLa cells grown to confluence separated by a stopper. Stopper was removed at t0 and cellular migration was imaged for the indicated times. (J) Quantification of the % of wound area occupied by migrating cells over time stopper removal (upper panel) and respective rate of closure (lower panel).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_5-A-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Epifluorescence microscopy images of supernatants from LLO-treated (0.5 nM 15 min) shCtlr, shGp96 or shNMHCIIA HeLa cells collected into poly-lysine-coated cover slips, fixed and stained with FITC-WGA (green) and DAPI (blue). Insets show PM blebs of variable sizes and DAPI staining confirms the absence of cell nuclei. Scale bar - 10 &#956;m. (B) Quantification of released PM blebs (total FITCWGA/field). Values are the means &#177; SEM (n&#8805;3). ***p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_5-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Flow cytometry analysis of the % of PI-positive shCtlr, shGp96 or shNMHCIIA HeLa cells. Cells were treated with (C) 0.5 nM LLO for the indicated times. Levels of PI incorporation by untreated cells were subtracted from all LLO-treated samples. Values are the mean &#177; SEM (n&#8805;4) and p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.5, **p&lt;0.01, ***p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_5-D</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Flow cytometry analysis of the % of PI-positive shCtlr, shGp96 or shNMHCIIA HeLa cells. Cells were treated with (D) 1.5 or 3 nM LLO for 15 min; or (E) 0.1 nM LLO for 10 min followed by LLO washed out and recovery for indicated times. Levels of PI incorporation by untreated cells were subtracted from all LLO-treated samples. Values are the mean &#177; SEM (n&#8805;4) and p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.5, **p&lt;0.01, ***p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_5-E</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Flow cytometry analysis of the % of PI-positive shCtlr, shGp96 or shNMHCIIA HeLa cells. Cells were treated with (E) 0.1 nM LLO for 10 min followed by LLO washed out and recovery for indicated times. Levels of PI incorporation by untreated cells were subtracted from all LLO-treated samples. Values are the mean &#177; SEM (n&#8805;4) and p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.5, **p&lt;0.01, ***p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_6-A</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Epifluorecence microscopy images of HeLa cells (A) left untreated or treated with LLO (0.5 nM, 15 min). Cells were incubated with exofacial-PS probe (Alexa-568 annexin A5) (red) 30 min prior fixation, immunolabelled for NMHCIIA (green) and stained with DAPI (blue). Insets show PM damage marked by exofacial-PS sites. Arrows indicate exofacial-PS associated with intracellular bacteria and in shCtrl cells with NMHCIIA bundles; arrowheads indicate NMHCIIA bundles associated with exofacial-PS sites without detectable bacteria.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_6-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Epifluorecence microscopy images of HeLa cells (B) infected with GFP-expressing wt Lm for 6 h. Cells were incubated with exofacial-PS probe (Alexa-568 annexin A5) (red) 30 min prior fixation, immunolabelled for NMHCIIA (green) and stained with DAPI (blue). Insets show PM damage marked by exofacial-PS sites. Arrows indicate exofacial-PS associated with intracellular bacteria and in shCtrl cells with NMHCIIA bundles; arrowheads indicate NMHCIIA bundles associated with exofacial-PS sites without detectable bacteria.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_6-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the % of infected cells with exofacial-PS sites in HeLa cells infected with wt Lm for 6 h. Data are the mean &#177;SEM (n=3) and p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.5.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_6-D-E</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 6-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-E) Flow cytometry analysis of the % of PI-positive shCtlr, shGp96 or shNMHCIIA HeLa and RAW264.7 cells, infected with GFP-expressing wt or &#916;hly Lm for 6 h. The levels of PI incorporation by uninfected cells were subtracted from infected samples. Values are the mean &#177; SEM (n&#8805;4) and p-values were calculated using one-way-ANOVA with Tukey post hoc analyses *p&lt;0.5, **p&lt;0.01, ***p&lt;0.001. PM permeability was assessed in cells harbouring equivalent numbers of intracellular bacteria (Fig Appendix Fig S3).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-A</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblots of NMHCIIA and Gp96 levels from whole cell lysates (WCL) and IP fractions (IP Gp96) of extracts of zebrafish larvae 3 dpf uninfected (U) or infected with wt or &#8710;hly Lm (low dose 200-1500 CFU) for 24h.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-B</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblots of Gp96 and tubulin levels from zebrafish 3 dpf larvae injected with control (Ctrl-mo) or Gp96 morpholino oligonucleotides (Gp96 mo).</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-C</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Confocal microscopy images of zebrafish larvae (Ctrl mo or Gp96 mo) infected (low dose) in the tail muscle, with the GFP-expressing wt or &#916;hly Lm for 24 h, immunolabelled for KDEL-proteins (green), and stained with phalloidin (actin, red) and DAPI (white). Images show actin rich structures at the cell cortex (arrows) and ER-KDEL puncta (arrowheads) in larvae infected with wt strain.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-D</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) CFU counts per zebrafish larvae (Ctrl or Gp96 mo) infected with wt (low dose) or &#916;hly (high dose &gt; 10,000 CFU) Lm and analysed at 0, 24, 48 hpi. Results are mean &#177; SEM (n&#8805;3) (horizontal bars) and each circle represents 1 larvae. p-values were calculated using one-way-ANOVA with Tukey post hoc analyses **p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-E</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Survival curves of zebrafish larvae (Ctrl-mo or Gp96-mo) infected with a wt (low dose) or &#916;hly (high dose &gt; 10,000 CFU) Lm. Results are the mean &#177; SEM (n&#8805;3). wt infection of Ctrl and Gp96 mo, n=28 larvae; &#916;hly infection of Gp96 mo n=13. p-values were calculated using Log Rank test, **p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>5286360 Figure_7-F</id>
    <infon key="sourcedata_document">2598</infon>
    <infon key="doi">10.15252/embr.201642833</infon>
    <infon key="pmc_id">5286360</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) CFU counts per zebrafish larvae infected with a high dose of &#8710;hly Lm at different times post-infection. Results are mean &#177; SEM (n&#8805;3) (horizontal bars); each point represents 1 larvae. See also Fig EV5.</text>
    </passage>
  </document>
</collection>
